Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma
2005
Doxorubicin pathways
2010 Standout
Leptospirosis in Humans
2014 Standout
Breast cancer
2016 Standout
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study
2007
Macrophages in immunoregulation and therapeutics
2023 Standout
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
2010
Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
2010
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
2015
18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy
2008
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
2011
Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature
2011
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Late Effects of Hodgkin’s Disease and Its Treatment
2009
A systematic review of Leptospira in water and soil environments
2020 Standout
Effects of Bone-Targeted Agents on Cancer Progression and Mortality
2012
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
2017 Standout
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
2015
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation
2010
Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease
2003
Late cardiotoxicity after treatment for Hodgkin lymphoma
2006
Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
2014
Cancer treatment and survivorship statistics, 2019
2019 Standout
How I treat mycosis fungoides and Sézary syndrome
2016
Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?
2016
Works of Sergio Cleto being referenced
Interferon and Low Dose Methotrexate Improve Outcome in Refractory Mycosis Fungoides/Sézary Syndrome
2007
Early identification of leptospirosis-associated pulmonary hemorrhage syndrome by use of a validated prediction model
2009
Antitumor effect of zoledronic acid in previously untreated patients with multiple myeloma
2007
Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy
2005
Residual Disease After Chemotherapy in Aggressive Malignant Lymphoma: The Role of Radiotherapy
2005
Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Stomach: Results of a Controlled Clinical Trial
2005
Second Lethal Events Associated with Treatment for Hodgkin's Disease: A Review of 2980 Patients Treated in a Single Mexican Institute
2000